ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Syndrome
Human Influenza

COVID-19 trials near Salt Lake City, UT, USA:

A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. (COVID-19)

vaccine (SARS-CoV-2 rS) adjuvanted with Matrix-M™ in previously mRNA COVID-19 vaccinated adult participants ≥18 years of age and ba-...

Active, not recruiting
COVID-19
Biological: XBB.1.5 Vaccine (single dose)
Biological: XBB.1.5 Vaccine (Booster)

Phase 2, Phase 3

Novavax
Novavax

Layton, Utah, United States and 29 other locations

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Salt Lake City, Utah, United States and 108 other locations

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Salt Lake City, Utah, United States and 123 other locations

The purpose of this research study is to find out how well two different 2023-2024 updated COVID-19 vaccines protect people from CO-...

Enrolling
COVID-19
SARS CoV 2 Infection
Biological: Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
Biological: Novavax COVID-19 vaccine (2023-2024 formula XBB containing)

Phase 4

Sarang K. Yoon, DO, MOH

Salt Lake City, Utah, United States

stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...

Enrolling
COVID-19
Device: RD-X19
Device: Sham
EmitBio

Salt Lake City, Utah, United States and 47 other locations

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Salt Lake City, Utah, United States and 28 other locations

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....

Enrolling
COVID-19
Drug: Placebo
Drug: EDP-235

Phase 2

Enanta Pharmaceuticals
Enanta Pharmaceuticals

Bountiful, Utah, United States and 20 other locations

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

Salt Lake City, Utah, United States and 217 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 214 other locations

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling
COVID-19
Drug: ritonavir
Drug: nirmatrelvir

Phase 1

Pfizer
Pfizer

Salt Lake City, Utah, United States and 32 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems